NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED
STATES.
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Flower One Holdings Inc. (“Flower One” or the
“Company”) (CSE: FONE) (OTCQB: FLOOF) is pleased to announce that it has filed and been receipted for an amended
and restated preliminary short form prospectus (the “Prospectus”) with securities regulatory authorities in all
provinces of Canada (except Québec) in connection with its overnight marketed public offering (the “Offering”) of
50,000 convertible debenture units (each, a “Debenture Unit”) of the Company for an offering size of up to
$50,000,000. The Offering was previously announced on March 4, 2019 with the price and terms previously announced on March 6,
2019.
Each Debenture Unit will consist of one 9.5% unsecured convertible debenture (each, a “Convertible
Debenture”) and 192 common share purchase warrants (each, a “Warrant”).
The Convertible Debentures will have a maturity of 36 months from the date of issuance (the “Maturity
Date”) and the principal amount of each Convertible Debenture shall be convertible, for no additional consideration,
into common shares of the Company (“Common Shares”) at the option of the holder at any time prior to the earlier
of: (i) the close of business on the Maturity Date, and (ii) the business day immediately preceding the date specified by the
Company for redemption of the Convertible Debentures upon a change of control at a conversion price equal to $2.60. If the
holder elects to convert the Convertible Debentures after a period that is six months and one day following closing of the
Offering, then the holder will also receive the Effective Interest (as defined below), payable in Common Shares at a price equal to
the daily volume weighted average trading price of the Common Shares on the Canadian Securities Exchange (the
“CSE”) for the consecutive 20 trading days of the Common Shares on the CSE preceding the date of such election or
cash, or a combination of cash and shares at the Company's option. The effective interest (“Effective Interest”)
is an amount equal to the interest that the holder would have received if the holder had held the Convertible Debentures until the
Maturity Date.
The Offering is being led by Mackie Research Capital Corporation and Canaccord Genuity Corp. (collectively, the
“Lead Agents”), on behalf of a syndicate of agents including Cormark Securities Inc., Eight
Capital, Industrial Alliance Securities Inc., and PI Financial Corp. (together with the Lead Agents, the
“Agents”).
The Company will use commercial reasonable efforts to obtain the necessary approvals to list the Convertible
Debentures, the Warrants, and the Common Shares issuable upon conversion of the Convertible Debentures and the Warrants on the
CSE.
The Offering is being made pursuant to the Prospectus filed in each of the provinces of Canada (except Québec),
and otherwise by private placement exemption in those jurisdictions where the Offering can lawfully be made, including the United
States and Europe. The Debenture Units (and the Convertible Debentures and the Warrants forming part of the Debenture Units)
have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities
Act”), or any state securities laws, and may only be offered or sold in the United States, to or for the account or
benefit of, persons in the United States or U.S. Persons (as defined in Regulation S under the U.S. Securities Act) directly by the
Company to institutional “accredited investors” meeting one or more of the criteria in Rule 501(a)(1), (2), (3) or (7) of
Regulation D under the U.S. Securities Act and in accordance with applicable state securities laws. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Debenture Units in any
jurisdiction in which such offer, solicitation or sale would be unlawful.
About Flower One Holdings Inc.
Flower One is sharply focused on quickly becoming the leading cannabis cultivator, producer and innovator in the
highly lucrative Nevada market. Flower One owns and operates a 25,000 square-foot cultivation and production facility in North Las
Vegas, with nine grow rooms, and owns the established NLV Organics consumer brand of cannabis products. The Company is also rapidly
converting its 455,000 square-foot greenhouse and production facility, which is the largest in the State of Nevada, for cultivating
and processing high-quality cannabis at scale. Combined, the flagship greenhouse facility and production facility (once fully
operational) and the North Las Vegas facility provide Flower One with 480,000 square feet of capacity for cultivation and
processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products. The Company is
fully licensed for medical marijuana cultivation and production, as well as recreational marijuana cultivation and production in
the state of Nevada and currently holds licensing agreements with their Brand Partners, Flyte Concentrates, Rapid-Dose
Therapeutics’ Quick Strip, Old Pal, Palms, HUXTON, CannAmerica Brands, and Gpen.
The common shares of the Company are traded on the CSE under the Company’s symbol “FONE” and in the United
States on the OTCQB under the symbol “FLOOF.” For more information, visit: https://flowerone.com
For inquiries please contact:
Flower One Holdings Inc.
Ken Villazor, President and CEO
416.200.7641
kvillazor@flower.com
Flower One investor relations inquiries
NATIONAL Capital Markets
416.848.9835
ir@flowerone.com
Flower One media inquiries
Natalie Martin
604.738.2220
flowerone@talkshopmedia.com
The CSE does not accept responsibility for the adequacy or accuracy of this press
release.
Forward Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward looking information”
within the meaning of Canadian and United States securities laws (collectively, “forward-looking statements”).
Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the
actual results of the Company to be materially different from historical results or from any future results expressed or implied by
such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are
urged to consider statements labeled with the terms “believes,” “belief,” “expects,” “intends,” “anticipates,” “potential,”
“should,” “may,” “will,” “plans,” “continue” or other similar expressions to be uncertain and forward looking. Readers are
cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
Forward-looking statements in this press release include, but are not limited to, the ability of the Company to close the Offering,
the amount of gross proceeds to be raised from the Offering, information or statements about the Company’s strategy, future
operations, prospects and the plans of management; the Company’s ability to achieve its objectives and plans, including the timing
and results of those objectives; the timing and the outcome of the conversion of its 455,000 square foot greenhouse and production
facility in Nevada; the Company’s potential to become the leading cannabis cultivator, producer and innovator in the highly
lucrative Nevada market; the scale and capacity of the Company’s cultivation, processing and high-volume packaging facilities in
Nevada, the size and continued growth, profitability, maturity, retail sales and size of the cannabis market in Nevada; and the
Company’s ability to fund its continued operations.
Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to
differ materially from those contained in the forward-looking statements, there can be other factors that cause results,
performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the Company’s
dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently
considered illegal under United States federal law; changes in laws; limited operating history; reliance on management;
requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion
and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.
The forward-looking statements contained in this press release are expressly qualified in their entirety by this
cautionary statement, the “Forward-Looking Statements” section contained in the Company’s most recent management’s discussion and
analysis (“MD&A”), which are available on SEDAR at www.sedar.com. All forward-looking statements in this press
release are made as of the date of this press release. The Company does not undertake to update any such forward-looking statements
whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements
contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the
Company’s public securities filings with the Canadian securities commissions, including the Company’s most recent
MD&A.
